Six consecutive male patients with stable systolic heart failure and CSA ( apnea-hypopnea index [ AHI ] 15 episodes/h ) were randomized to a double-blind crossover protocol with acetazolamide or placebo received 1 hour before bedtime for six nights with 2 weeks of wash-out .